The impact of the milk glycobiome on the neonate gut microbiota

Annual Review of Animal Biosciences

Volumn 3, Issue , 2015, Pages 419-445

  Pacheco, Alline R ^a   Barile, Daniela ^a   Underwood, Mark A ^a,b   Mills, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bifidobacteria; glycobiome; milk bioactives; milk oligosaccharides; neonatal microbiota

Indexed keywords

BOVINAE;

GLYCOLIPID; GLYCOPROTEIN; OLIGOSACCHARIDE; PREBIOTIC AGENT;

ANIMAL; BACTERIAL INFECTION; BACTERIUM; BREAST FEEDING; BREAST MILK; CHEMISTRY; HUMAN; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MICROFLORA; MILK; NEWBORN;

ANIMALS; ANIMALS, NEWBORN; BACTERIA; BACTERIAL INFECTIONS; BREAST FEEDING; GLYCOLIPIDS; GLYCOPROTEINS; HUMANS; INFANT, NEWBORN; INTESTINES; MICROBIOTA; MILK; MILK, HUMAN; OLIGOSACCHARIDES; PREBIOTICS;

EID: 84923169158     PISSN: 21658102     EISSN: 21658110     Source Type: Journal    
DOI: 10.1146/annurev-animal-022114-111112     Document Type: Article

References (189)

1. Am. Acad. Pediatr. 2012. Breastfeeding and the use of human milk. Pediatrics 129:e827-41
2. Ballard O, Morrow AL. 2013. Human milk composition: nutrients and bioactive factors. Pediatr. Clin. North Am. 60:49-74
3. Haschke F, Haiden N, Detzel P, Yarnoff B, Allaire B, Haschke-Becher E. 2013. Feeding patterns during the first 2 years and health outcome. Ann. Nutr. Metab. 62(Suppl. 3):16-25
4. Ruiz-PalaciosGM,Calva JJ, Pickering LK, Lopez-Vidal Y, Volkow P, et al. 1990. Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk. J. Pediatr. 116:707-13
5. ClavanoNR. 1982.Mode of feeding and its effect on infant mortality and morbidity. J. Trop. Pediatr. 28:287-93
6. Chen A, Rogan WJ. 2004. Breastfeeding and the risk of postneonatal death in the United States. Pediatrics 113:e435-39
7. Andres A, Cleves MA, Bellando JB, Pivik RT, Casey PH, Badger TM. 2012. Developmental status of 1-year-old infants fed breast milk, cow 's milk formula, or soy formula. Pediatrics 129:1134-40
8. Alvarez-Uria G, Midde M, Pakam R, Bachu L, Naik PK. 2012. Effect of formula feeding and breastfeeding on child growth, infant mortality, and HIV transmission in children born to HIV-infected pregnant women who received triple antiretroviral therapy in a resource-limited setting: data from an HIV cohort study in India. ISRN Pediatr. 2012:763591
9. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, et al. 2006. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 296:794-805
10. Chatterton DE, Nguyen DN, Bering SB, Sangild PT. 2013. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int. J. Biochem. Cell Biol. 45:1730-47
11. Zivkovic AM, German JB, Lebrilla CB, Mills DA. 2011. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. PNAS 108(Suppl. 1):4653-58
12. Apweiler R, HermjakobH, Sharon N. 1999. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473:4-8
13. Peterson R, Cheah WY, Grinyer J, Packer N. 2013. Glycoconjugates in human milk: protecting infants from disease. Glycobiology 23:1425-38
14. Ruhaak LR, Lebrilla CB. 2012. Analysis and role of oligosaccharides in milk. BMB Rep. 45:442-51
15. Wu S, Tao N, German JB, Grimm R, Lebrilla CB. 2010. Development of an annotated library of neutral human milk oligosaccharides. J. Proteome Res. 9:4138-51
16. Bode L. 2012. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 22:1147-62
17. Oftedal OT. 2012. The evolution of milk secretion and its ancient origins. Animal 6:355-68
18. Albrecht S, Schols HA, van den Heuvel EG, Voragen AG, Gruppen H. 2011. Occurrence of oligosaccharides in feces of breast-fed babies in their first six months of life and the corresponding breast milk. Carbohydr. Res. 346:2540-50
19. Rudloff S, Kunz C. 2012. Milk oligosaccharides and metabolism in infants. Adv. Nutr. 3:398S-405S
20. Gnoth MJ, Kunz C, Kinne-Saffran E, Rudloff S. 2000. Human milk oligosaccharides are minimally digested in vitro. J. Nutr. 130:3014-20
21. Albrecht S, Schols HA, van den HeuvelEGHM, Voragen AGJ, Gruppen H. 2010. CE-LIF-MSn profiling of oligosaccharides in human milk and feces of breast-fed babies. Electrophoresis 31:1264-73
22. Rudloff S, Pohlentz G, Diekmann L, Egge H, Kunz C. 1996. Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula. Acta Paediatr. 85:598-603
23. Rudloff S, Pohlentz G, Borsch C, Lentze MJ, Kunz C. 2012. Urinary excretion of in vivo 13C-labelled milk oligosaccharides in breastfed infants. Br. J. Nutr. 107:957-63
24. Ruhaak LR,Lebrilla CB. 2012.Advances inanalysisof humanmilkoligosaccharides. Adv. Nutr. 3:406S-14S
25. NinonuevoMR, Park Y, Yin H, Zhang J, Ward RE, et al. 2006.Astrategy for annotating the human milk glycome. J. Agric. Food Chem. 54:7471-80
26. Wu S, Grimm R, German JB, Lebrilla CB. 2011. Annotation and structural analysis of sialylated human milk oligosaccharides. J. Proteome Res. 10:856-68
27. Zivkovic AM, Barile D. 2011. Bovine milk as a source of functional oligosaccharides for improving human health. Adv. Nutr. 2:284-89
28. Tao N, DePeters EJ, Freeman S, German JB, Grimm R, Lebrilla CB. 2008. Bovine milk glycome. J. Dairy Sci. 91:3768-78
29. Tao N, DePeters EJ, German JB, Grimm R, Lebrilla CB. 2009. Variations in bovine milk oligosaccharides during early and middle lactation stages analyzed by high-performance liquid chromatography-chip/ mass spectrometry. J. Dairy Sci. 92:2991-3001
30. Barile D, Marotta M, Chu C, Mehra R, Grimm R, et al. 2010. Neutral and acidic oligosaccharides in Holstein-Friesian colostrum during the first 3 days of lactation measured by high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. J. Dairy Sci. 93:3940-49
31. Aldredge DL, Geronimo MR, Hua S, Nwosu CC, Lebrilla CB, Barile D. 2013. Annotation and structural elucidation of bovine milk oligosaccharides and determination of novel fucosylated structures. Glycobiology 23:664-76
32. Barile D, Tao N, Lebrilla CB, Coisson JD, Arlorio M, German JB. 2009. Permeate from cheese whey ultrafiltration is a source of milk oligosaccharides. Int. Dairy J. 19:524-30
33. Lonnerdal B. 2003. Nutritional and physiologic significance of human milk proteins. Am. J. Clin. Nutr. 77:1537S-43S
34. Le Parc A, Dallas DC, Duaut S, Leonil J, Martin P, Barile D. 2014. Characterization of goat milk lactoferrin N-glycans and comparison with the N-glycomes of human and bovine milk. Electrophoresis 35:1560-70
35. Tomita M, Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K. 1991. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 74:4137-42
36. Yamauchi K, TomitaM,Giehl TJ, EllisonRT3rd. 1993. Antibacterial activity of lactoferrin and a pepsinderived lactoferrin peptide fragment. Infect. Immun. 61:719-28
37. O'Riordan N, Kane M, Joshi L, Hickey RM. 2014. Structural and functional characteristics of bovine milk protein glycosylation. Glycobiology 24:220-36
38. Davidson LA, Lonnerdal B. 1987. Persistence of human milk proteins in the breast-fed infant. Acta Paediatr. Scand. 76:733-40
39. Wang B, Brand-Miller J, McVeagh P, Petocz P. 2001. Concentration and distribution of sialic acid in human milk and infant formulas. Am. J. Clin. Nutr. 74:510-15
40. Idota T, Kawakami H, Nakajima I. 1994. Growth-promoting effects of N-acetylneuraminic acidcontaining substances on Bifidobacteria. Biosci. Biotechnol. Biochem. 58:1720-22
41. Yvon M, Beucher S, Guilloteau P, Le Huerou-Luron I, Corring T. 1994. Effects of caseinomacropeptide (CMP) on digestion regulation. Reprod. Nutr. Dev. 34:527-37
42. Lloyd KO, Furukawa K. 1998. Biosynthesis and functions of gangliosides: recent advances. Glycoconj. J. 15:627-36
43. Lee H, An HJ, Lerno LA Jr, German JB, Lebrilla CB. 2011. Rapid profiling of bovine and human milk gangliosides by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry. Int. J. Mass Spectrom. 305:138-50
44. Pan XL, Izumi T. 2000. Variation of the ganglioside compositions of human milk, cow's milk and infant formulas. Early Hum. Dev. 57:25-31
45. Lee H, German JB, Kjelden R, Lebrilla CB, Barile D. 2013. Quantitative analysis of gangliosides in bovine milk and colostrum-based dairy products by ultrahigh performance liquid chromatography-tandem mass spectrometry. J. Agric. Food Chem. 61:9689-96
46. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837-48
47. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-38
48. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-20
49. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, et al. 2012. Host-gut microbiota metabolic interactions. Science 336:1262-67
50. SpeesAM,Lopez CA, KingsburyDD,Winter SE, Bäumler AJ. 2013. Colonization resistance: Battle of the bugs or ménage à trois with the host? PLOS Pathog. 9:e1003730
51. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, et al. 2012. Human gut microbiome viewed across age and geography. Nature 486:222-27
52. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559-63
53. Cho I, Blaser MJ. 2012. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13:260-70
54. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. PNAS 102:11070-75
55. Turnbaugh PJ, Ley RE, Mahowald MA,Magrini V,Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-31
56. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, et al. 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55:205-11
57. Normann E, Fahlen A, Engstrand L, Lilja HE. 2013. Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr. 102:129-36
58. Mai V, Young CM, Ukhanova M, Wang X, Sun Y, et al. 2011. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLOS ONE 6:e20647
59. Wu N, Yang X, Zhang R, Li J, Xiao X, et al. 2013. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 66:462-70
60. Walker A. 2010. Breast milk as the gold standard for protective nutrients. J. Pediatr. 156:S3-7
61. Caicedo RA, Schanler RJ, Li N, Neu J. 2005. The developing intestinal ecosystem: implications for the neonate. Pediatr. Res. 58:625-28
62. Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. 2004. Developmentally regulated IkB expression in intestinal epitheliumand susceptibility to flagellin-induced inflammation. PNAS 101:7404-8
63. Walker WA. 2013. Initial intestinal colonization in the human infant and immune homeostasis. Ann. Nutr. Metab. 63(Suppl. 2):8-15
64. Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, Retetangos C. 2010. Mode of delivery affects the bacterial community in the newborn gut. Early Hum. Dev. 86(Suppl. 1):13-15
65. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, et al. 2006. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511-21
66. Huurre A, Kalliomaki M, Rautava S, Rinne M, Salminen S, Isolauri E. 2008. Mode of delivery-effects on gut microbiota and humoral immunity. Neonatology 93:236-40
67. Huda MN, Lewis Z, Kalanetra KM, Rashid M, Ahmad SM, et al. 2014. Stool microbiota and vaccine responses of infants. Pediatrics 134(2):e362-72
68. Fanaro S, Chierici R, Guerrini P, Vigi V. 2003. Intestinal microflora in early infancy: composition and development. Acta Paediatr. Suppl. 91:48-55
69. Mackie RI, Sghir A, Gaskins HR. 1999. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69:1035S-45S
70. Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, et al. 2014. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 510:417-21
71. Scholtens PA, Oozeer R, Martin R, Amor KB, Knol J. 2012. The early settlers: intestinal microbiology in early life. Annu. Rev. Food Sci. Technol. 3:425-47
72. Berni Canani R, Passariello A, Buccigrossi V, Terrin G, Guarino A. 2008. The nutritional modulation of the evolving intestine. J. Clin. Gastroenterol. 42(Suppl. 3 Pt. 2):S197-200
73. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, et al. 2012. Diversity of bifidobacteria within the infant gut microbiota. PLOS ONE 7:e36957
74. Avershina E, Storro O, Oien T, Johnsen R, Wilson R, et al. 2013. Bifidobacterial succession and correlation networks in a large unselected cohort of mothers and their children. Appl. Environ. Microbiol. 79:497-507
75. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, et al. 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 30:61-67
76. Jost T, Lacroix C, Braegger CP, Chassard C. 2012. New insights in gut microbiota establishment in healthy breast fed neonates. PLOS ONE 7:e44595
77. Roger LC, McCartney AL. 2010. Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology 156:3317-28
78. Turroni F, Foroni E, Pizzetti P, Giubellini V, Ribbera A, et al. 2009. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 75:1534-45
79. De Leoz MLA, Gaerlan SC, Strum JS, Dimapasoc LM, Mirmiran M, et al. 2012. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J. Proteome Res. 11:4662-72
80. Neu J, Walker WA. 2011. Necrotizing enterocolitis. N. Engl. J. Med. 364:255-64
81. Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA. 2001. Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr. Res. 49:589-93
82. Arboleya S, Binetti A, Salazar N, Fernandez N, Solis G, et al. 2012. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol. Ecol. 79:763-72
83. Butel MJ, Suau A, Campeotto F, Magne F, Aires J, et al. 2007. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J. Pediatr. Gastroenterol. Nutr. 44:577-82
84. Johnson TJ, Patel AL, Jegier BJ, Engstrom JL, Meier PP. 2013. Cost of morbidities in very low birth weight infants. J. Pediatr. 162:243-49.e1
85. Morrow AL, Meinzen-Derr J, Huang P, Schibler KR, Cahill T, et al. 2011. Fucosyltransferase 2 nonsecretor and low secretor status predicts severe outcomes in premature infants. J. Pediatr. 158:745-51
86. Downard CD, Grant SN, Maki AC, Krupski MC, Matheson PJ, et al. 2012. Maternal cigarette smoking and the development of necrotizing enterocolitis. Pediatrics 130:78-82
87. Torrazza RM, UkhanovaM,Wang X, Sharma R, Hudak ML, et al. 2013. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLOS ONE 8:e83304
88. Morrow AL, Lagomarcino AJ, Schibler KR, Taft DH, Yu Z, et al. 2013. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome 1:13
89. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, et al. 2009. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 3:944-54
90. Jenke AC, Postberg J, Mariel B, Hensel K, Foell D, et al. 2013. S100A12 and hBD2 correlate with the composition of the fecal microflora in ELBW infants and expansion of E. coli is associated with NEC. BioMed. Res. Int. 2013:150372
91. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, et al. 2009. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123:58-66
92. Gupta RW, Tran L, Norori J, Ferris MJ, Eren AM, et al. 2013. Histamine-2 receptor blockers alter the fecal microbiota in premature infants. J. Pediatr. Gastroenterol. Nutr. 56:397-400
93. Terrin G, Passariello A, De Curtis M, Manguso F, Salvia G, et al. 2012. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 129:e40-45
94. UnderwoodMA,KalanetraKM,BokulichNA, Lewis ZT, MirmiranM, et al. 2013.Acomparison of two probiotic strains of bifidobacteria in premature infants. J. Pediatr. 163:1585-91.e9
95. AlFaleh K, Anabrees J, Bassler D, Al-KharfiT. 2014. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 4:CD005496
96. Meinzen-Derr J, Poindexter B, Wrage L, Morrow AL, Stoll B, Donovan EF. 2009. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J. Perinatol. 29:57-62
97. Underwood MA. 2013. Human milk for the premature infant. Pediatr. Clin. North Am. 60:189-207
98. Hunter CJ, Bean JF. 2013. Cronobacter: an emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis. J. Perinatol. 33:581-85
99. Cristofalo EA, Schanler RJ, Blanco CL, Sullivan S, Trawoeger R, et al. 2013. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J. Pediatr. 163:1592-95.e1
100. Gyorgy P, Norris RF, Rose CS. 1954. Bifidus factor. I. A variant of Lactobacillus bifidus requiring a special growth factor. Arch. Biochem. Biophys. 48:193-201
101. Gauhe A, Gyorgy P, Hoover JRE, Kuhn R, Rose CS, et al. 1954. Bifidus factor. 4. Preparations obtained from human milk. Arch. Biochem. Biophys. 48:214-24
102. Garrido D, Dallas DC, Mills DA. 2013. Consumption of human milk glycoconjugates by infantassociated bifidobacteria: mechanisms and implications. Microbiology 159:649-64
103. Marcobal A, Sonnenburg JL. 2012. Human milk oligosaccharide consumption by intestinal microbiota. Clin. Microbiol. Infect. 18(Suppl. 4):12-15
104. Ward RE, NiñonuevoM,Mills DA, Lebrilla CB, German JB. 2006. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl. Environ. Microbiol. 72:4497-99
105. Marcobal A, Barboza M, Froehlich JW, Block DE, German JB, et al. 2010. Consumption of human milk oligosaccharides by gut-related microbes. J. Agric. Food Chem. 58:5334-40
106. LoCascio RG, Niñonuevo MR, Freeman SL, Sela DA, Grimm R, et al. 2007. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J. Agric. Food Chem. 55:8914-19
107. Locascio RG, Niñonuevo MR, Kronewitter SR, Freeman SL, German JB, et al. 2009. A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb. Biotechnol. 2:333-42
108. Ruiz-Moyano S, Totten SM, Garrido D, Smilowitz JT, German JB, et al. 2013. Variation in consumption of human milk oligosaccharides by infant-gut associated strains of Bifidobacterium breve. Appl. Environ. Microbiol. 79:6040-49
109. Yu ZT, Chen C, Newburg DS. 2013. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology 23:1281-92
110. MarcobalA, BarbozaM,Sonnenburg ED, Pudlo N, Martens EC, et al. 2011. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 10:507-14
111. LoCascio RG, Desai P, Sela DA, Weimer B, Mills DA. 2010. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Appl. Environ. Microbiol. 76:7373-81
112. Kim JH, An HJ, Garrido D, German JB, Lebrilla CB, Mills DA. 2013. Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycans. PLOS ONE 8:e57535
113. Sela DA, Garrido D, Lerno L, Wu S, Tan K, et al. 2012. Bifidobacterium longum subsp. infantis ATCC 15697 a-fucosidases are active on fucosylated human milk oligosaccharides. Appl. Environ. Microbiol. 78:795-803
114. Ashida H, Miyake A, Kiyohara M, Wada J, Yoshida E, et al. 2009. Two distinct a-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19:1010-17
115. Sela DA, Li Y, Lerno L, Wu S, Marcobal AM, et al. 2011. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J. Biol. Chem. 286:11909-18
116. Garrido D, Ruiz-Moyano S, Mills DA. 2012. Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. Anaerobe 18:430-35
117. Yoshida E, Sakurama H, Kiyohara M, Nakajima M, Kitaoka M, et al. 2012. Bifidobacterium longum subsp. infantis uses two different b-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 22:361-68
118. Miwa M, Horimoto T, Kiyohara M, Katayama T, Kitaoka M, et al. 2010. Cooperation of b-galactosidase and b-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology 20:1402-9
119. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, et al. 2008. Bifidobacterium bifidum lacto-Nbiosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl. Environ. Microbiol. 74:3996-4004
120. Sela DA, Mills DA. 2010. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol. 18:298-307
121. Egan M, O'Connell Motherway M, Ventura M, van Sinderen D. 2014. Metabolism of sialic acid by Bifidobacterium breve UCC2003. Appl. Environ. Microbiol. 80:4414-26
122. Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, et al. 2004. Molecular cloning and characterization of Bifidobacterium bifidum 1,2-a-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J. Bacteriol. 186:4885-93
123. Kiyohara M, Tanigawa K, Chaiwangsri T, Katayama T, Ashida H, Yamamoto K. 2011. An exo-a-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology 21:437-47
124. Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, et al. 2012. Fucose sensing regulates bacterial intestinal colonization. Nature 492:113-17
125. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, et al. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502:96-99
126. Tang XS, Shao H, Li TJ, Tang ZR, Huang RL, et al. 2012. Dietary supplementation with bovine lactoferrampin-lactoferricin produced by Pichia pastoris fed-batch fermentation affects intestinal microflora in weaned piglets. Appl. Biochem. Biotechnol. 168:887-98
127. Hu W, Zhao J, Wang J, Yu T, Li N. 2012. Transgenic milk containing recombinant human lactoferrin modulates the intestinal flora in piglets. Biochem. Cell Biol. 90:485-96
128. BruckWM, Graverholt G, Gibson GR. 2003. A two-stage continuous culture system to study the effect of supplemental a-lactalbumin and glycomacropeptide on mixed cultures of human gut bacteria challenged with enteropathogenic Escherichia coli and Salmonella serotype Typhimurium. J. Appl.Microbiol. 95:44-53
129. Chen Q, Cao J, Jia Y, Liu X, Yan Y, Pang G. 2012. Modulation of mice fecal microbiota by administration of casein glycomacropeptide. Microbiol. Res. 3:e3
130. RahmanMM,Kim WS,Ito T, KumuraH, ShimazakiK. 2009. Growth promotion and cell binding ability of bovine lactoferrin to Bifidobacterium longum. Anaerobe 15:133-37
131. Petschow BW, Talbott RD, Batema RP. 1999. Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level. J. Med. Microbiol. 48:541-49
132. Oda H, Wakabayashi H, Yamauchi K, Sato T, Xiao JZ, et al. 2013. Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin. Appl. Environ. Microbiol. 79:1843-49
133. Liepke C, Adermann K, Raida M, Magert HJ, ForssmannWG, Zucht HD. 2002. Human milk provides peptides highly stimulating the growth of bifidobacteria. Eur. J. Biochem. 269:712-18
134. Garrido D, Nwosu C, Ruiz-Moyano S, Aldredge D, German JB, et al. 2012. Endo-b-N-acetylglucosaminidases from infant gut-associated bifidobacteria release complex N-glycans from human milk glycoproteins. Mol. Cell. Proteomics 11:775-85
135. Kiyohara M, Nakatomi T, Kurihara S, Fushinobu S, Suzuki H, et al. 2012. a-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway. J. Biol. Chem. 287:693-700
136. Rueda R, Sabatel JL, Maldonado J, Molina-Font JA, Gil A. 1998. Addition of gangliosides to an adapted milk formula modifies levels of fecal Escherichia coli in preterm newborn infants. J. Pediatr. 133:90-94
137. Lee H, Garrido D, Mills DA, Barile D. 2014. Hydrolysis of milk gangliosides by infant-gut associated bifidobacteria determined by microfluidic chips and high-resolution mass spectrometry. Electrophoresis 35:1742-50
138. Morrow AL, Rangel JM. 2004. Human milk protection against infectious diarrhea: implications for prevention and clinical care. Semin. Pediatr. Infect. Dis. 15:221-28
139. Lanari M, Prinelli F, Adorni F, Di Santo S, Faldella G, et al. 2013. Maternal milk protects infants against bronchiolitis during the first year of life. Results from an Italian cohort of newborns. Early Hum. Dev. 89(Suppl. 1):S51-57
140. Duffy LC, Faden H, Wasielewski R, Wolf J, Krystofik D. 1997. Exclusive breastfeeding protects against bacterial colonization and day care exposure to otitis media. Pediatrics 100:E7
141. Abdel-Hafeez EH, Belal US, Abdellatif MZ, Naoi K, Norose K. 2013. Breast-feeding protects infantile diarrhea caused by intestinal protozoan infections. Korean J. Parasitol. 51:519-24
142. Newburg DS, Ruiz-Palacios GM,Morrow AL. 2005. Humanmilk glycans protect infants against enteric pathogens. Annu. Rev. Nutr. 25:37-58
143. Krachler AM, Orth K. 2013. Targeting the bacteria-host interface: strategies in anti-adhesion therapy. Virulence 4:284-94
144. Jiang X, Huang PW, Zhong WM, Morrow AL, Ruiz-Palacios GM, Pickering LK. 2004. Human milk contains elements that block binding of noroviruses to histo-blood group antigens in saliva. Prot. Infants Hum. Milk 554:447-50
145. Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE. 2013. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLOS ONE 8:e72788
146. Zhang XF, Tan M, Chhabra M, Dai YC, Meller J, Jiang X. 2013. Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections. PLOS ONE 8:e69379
147. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, et al. 2004. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J. Pediatr. 145:297-303
148. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-40
149. Manthey CF, Autran CA, Eckmann L, Bode L. 2013. Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment in vitro andEPECcolonization in suckling mice. J. Pediatr. Gastroenterol. Nutr. 58:167-70
150. Weichert S, Jennewein S, Hufner E, Weiss C, Borkowski J, et al. 2013. Bioengineered 20 -fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines. Nutr. Res. 33:831-38
151. Martin-Sosa S, Martin MJ, Hueso P. 2002. The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. J. Nutr. 132:3067-72
152. Lin AE, Autran CA, Espanola SD, Bode L, Nizet V. 2014. Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity. J. Infect. Dis. 209:389-98
153. Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ. 2012. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol. Rev. 36:616-48
154. Greenhow TL, Hung YY, Herz AM, Losada E, Pantell RH. 2013. The changing epidemiology of serious bacterial infections in young infants. Pediatr. Infect. Dis. J. 33:595-99
155. Jantscher-Krenn E, Lauwaet T, Bliss LA, Reed SL, Gillin FD, Bode L. 2012.Humanmilk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro. Br. J. Nutr. 108:1839-46
156. Barboza M, Pinzon J, Wickramasinghe S, Froehlich JW,Moeller I, et al. 2012. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Mol. Cell. Proteomics 11:M111.015248
157. Marr AK, Jenssen H, Moniri MR, Hancock RE, Pante N. 2009. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochimie 91:160-64
158. Shestakov A, Jenssen H, Nordstrom I, Eriksson K. 2012. Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice. Antiviral Res. 93:340-45
159. Valimaa H, Tenovuo J, Waris M, Hukkanen V. 2009. Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread. Virol. J. 6:53
160. Hooper LV, Macpherson AJ. 2010. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10:159-69
161. Rogier EW, Frantz AL, Bruno ME, Wedlund L, Cohen DA, et al. 2014. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. PNAS 111:3074-79
162. Hughes GJ, Reason AJ, Savoy L, Jaton J, Frutiger-Hughes S. 1999. Carbohydrate moieties in human secretory component. Biochim. Biophys. Acta 1434:86-93
163. Royle L, Roos A, Harvey DJ, Wormald MR, Van Gijlswijk-Janssen D, et al. 2003. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J. Biol. Chem. 278:20140-53
164. Mathias A, Corthesy B. 2011. Recognition of gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates. J. Biol. Chem. 286:17239-47
165. Cravioto A, Tello A, Villafán H, Ruiz J, del Vedovo S, Neeser JR. 1991. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 163:1247-55
166. Falk P, Roth KA, Boren T, Westblom TU, Gordon JI, Normark S. 1993. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. PNAS 90:2035-39
167. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, et al. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373-77
168. Wold AE, Mestecky J, Tomana M, Kobata A, Ohbayashi H, et al. 1990. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 58:3073-77
169. Connell I, Agace W, Klemm P, Schembri M, Marild S, Svanborg C. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. PNAS 93:9827-32
170. Aniansson G, Andersson B, Lindstedt R, Svanborg C. 1990. Anti-adhesive activity of human casein against Streptococcus pneumoniae and Haemophilus influenzae. Microb. Pathog. 8:315-23
171. Stromqvist M, Falk P, Bergstrom S, Hansson L, Lonnerdal B, et al. 1995. Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. J. Pediatr. Gastroenterol. Nutr. 21:288-96
172. Rueda R. 2007. The role of dietary gangliosides on immunity and the prevention of infection. Br. J. Nutr. 98(Suppl. 1):S68-73
173. Idota T, Kawakami H. 1995. Inhibitory effects of milk gangliosides on the adhesion of Escherichia coli to human intestinal carcinoma cells. Biosci. Biotechnol. Biochem. 59:69-72
174. Otnaess AB, Laegreid A, Ertresvag K. 1983. Inhibition of enterotoxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk. Infect. Immun. 40:563-69
175. Laegreid A, Otnaess AB, Fuglesang J. 1986. Human and bovine milk: comparison of ganglioside composition and enterotoxin-inhibitory activity. Pediatr. Res. 20:416-21
176. Newburg DS, Ashkenazi S, Cleary TG. 1992. Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3. J. Infect. Dis. 166:832-36
177. Pacheco AR, Sperandio V. 2012. Shiga toxin in enterohemorrhagic E. coli: regulation and novel antivirulence strategies. Front. Cell. Infect. Microbiol. 2:81
178. Saeland E, de Jong MA, Nabatov AA, Kalay H, Geijtenbeek TB, van Kooyk Y. 2009. MUC1 in human milk blocks transmission of humanimmunodeficiency virus from dendritic cells toTcells. Mol. Immunol. 46:2309-16
179. Wu L, KewalRamani VN. 2006. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 6:859-68
180. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-97
181. Hong PW, Flummerfelt KB, de Parseval A, Gurney K, Elder JH, Lee B. 2002. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DCSIGN binding. J. Virol. 76:12855-65
182. Hong PW, Nguyen S, Young S, Su SV, Lee B. 2007. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120. J. Virol. 81:8325-36
183. + T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins. Immunology 123:508-18
184. YolkenRH, Peterson JA, Vonderfecht SL, Fouts ET, Midthun K, Newburg DS. 1992.Humanmilk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J. Clin. Investig. 90:1984-91
185. Schroten H, Hanisch FG, Plogmann R, Hacker J, Uhlenbruck G, et al. 1992. Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction. Infect. Immun. 60:2893-99
186. Liu B,YuZ, Chen C, Kling DE, Newburg DS. 2012.Humanmilk mucin 1 and mucin 4 inhibit Salmonella enterica serovar Typhimurium invasion of human intestinal epithelial cells in vitro. J. Nutr. 142:1504-9
187. Dallas DC, Guerrero A, Khaldi N, Castillo PA, Martin WF, et al. 2013. Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides. J. Proteome Res. 12:2295-304
188. Hakansson AP, Roche-Hakansson H, Mossberg AK, Svanborg C. 2011. Apoptosis-like death in bacteria induced by HAMLET, a human milk lipid-protein complex. PLOS ONE 6:e17717
189. Garrido D, Dallas DC, Mills DA. 2013. Consumption of human milk glycoconjugates by infantassociated bifidobacteria: mechanisms and implications. Microbiology 159:649-64